Skip to main content

Table 2 Correlation analysis of SCC antigen levels with clinical characteristics of patients with cervical squamous cell carcinoma

From: Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Clinical characteristics Conventional group NACT group
SCC antigen ISCC SSCC OSCC FSCC TSCC FSCC (%) TSCC (%)
Age Spearman CC 0.204 0.064 0.095 0.134 0.073 0.037 0.102 0.057
P value 0.220 0.616 0.457 0.295 0.565 0.774 0.421 0.655
Tumor differentiation degree Spearman CC 0.076 0.111 0.195 0.117 0.109 0.158 −0.016 0.126
P value 0.644 0.381 0.123 0.359 0.389 0.212 0.903 0.323
Number of positive lymph nodes Spearman CC 0.673 0.326 0.436 0.395 0.237 0.274 0.060 0.089
P value < 0.001 0.009 < 0.001 0.001 0.059 0.029 0.637 0.484
Maximum length of the lesion before chemotherapy Spearman CC 0.643 0.352 0.217 0.212 0.429 0.402 0.383 0.283
P value < 0.001 0.004 0.085 0.096 < 0.001 0.001 0.002 0.023
Maximum length of the lesion after chemotherapy Spearman CC 0.046 0.142 0.183 0.019 0.040 −0.020 −0.075
P value 0.718 0.263 0.151 0.880 0.754 0.874 0.558
Narrowing extent of the lesion Spearman CC 0.326 0.083 0.003 0.413 0.391 0.387 0.424
P value 0.008 0.515 0.980 0.001 0.001 0.002 <0.001
Survival time Spearman CC −0.060 −0.154 −0.263 −0.265 −0.086 − 0.030 0.033 0.111
P value 0.716 .0.227 0.037 0.037 0.502 0.816 0.800 0.387
  1. CC Correlation Coefficient, SCC antigen Squamous cell carcinoma antigen, ISCC The SCC antigen level before the first chemotherapy, SSCC The SCC antigen level after the first chemotherapy, OSCC The SCC antigen level after the second chemotherapy, FSCC The absolute value of the decreased SCC antigen level after the first chemotherapy, TSCC The absolute value of the decreased SCC antigen level after total chemotherapy, FSCC (%) Percentage decrease in SCC antigen level after the first chemotherapy, TSCC (%) Percentage decrease in SCC antigen level after total chemotherapy